Treatment with BAC protects against IL-1β-induced inflammation in chondrocytes by elevating the expression of IL-11 through activating AP-1 transcriptional activity, indicating the therapeutic potential of BAC in patients with osteoarthritis (Yang et al., 2014). The gene discussed is IL1B; the disease is minimally invasive lung adenocarcinoma.